The Aga Khan's 4-year-old Breeders' Cup Turf winner Tarnawa will remaining in training through her 5-year-old season, according to the Irish Times. The daughter of Shamardal gave trainer Dermot Weld his first Cup winner this year, and the trainer hopes to target the Prix de l'Arc de Triomphe in 2021.
“The plan is for Tarnawa to stay in training next year, which is good news,” Weld told the Irish Times. “We will look forward to training her for [an] autumn campaign again which will hopefully include the Prix de l'Arc de Triomphe.”
An eight-time winner from 14 career starts, Tarnawa has three G1 wins to her name.
A day after winning the Group 1 Prix de l'Arc de Triomphe in France, Sottsass was retired from racing, and he will stand for the Coolmore operation in 2021, Racing Post reports.
The 4-year-old Siyouni colt was campaigned in a 50/50 partnership between Peter Brant and Coolmore, the latter of which purchased its stake in January. Monday's announcement removes a key contender from this year's Breeders' Cup Turf, in which Sottsass earned a “Win and You're In” berth by virtue of his Arc score.
Trained by Jean-Claude Rouget, Sottsass has been a high-level runner in France over the past two seasons.
During his 3-year-old campaign last season, the colt won the G1 Prix du Jockey Club at Chantilly and the G2 Prix Niel at Longchamp before finishing third to Enable in that year's Arc.
At four, he won the G1 Prix Ganay at Chantilly and he finished second in the G3 Prix Gontaut-Biron Hong Kong Jockey Club at Deauville ahead of his Arc victory.
Bred in France by S.A.S.U. Ecurie Des Moneaux, Sottsass is a half-brother to Sistercharlie, the 2018 Eclipse Award winner for champion turf female, who is also campaigned by Brant. Sistercharlie is a contender for this year's Breeders' Cup Filly and Mare Turf.
Peter Brant's return to Thoroughbred racing and breeding in 2016 after a nearly 25-year hiatus hit its pinnacle on Sunday with a victory by Sottsass in the Group 1 Prix de l'Arc de Triomphe in Paris, France. The 4-year-old colt by the French stallion Siyouni, trained by Jean-Claude Rouget and ridden to victory by Cristian Demuro, had no trouble with the heavy ground at ParisLongchamp, defeating In Swoop and pace-setting Persian King in the 12-furlong European classic for 3-year-olds and up.
Juddmonte Farms Enable finished sixth in her bid for a record third Arc de Triomphe victory, Jockey Frankie Dettori said of the John Gosden runner: “She hated that ground. I knew my fate at the 400.”
The victory was the first in the Arc de Triomphe for Brant, Demuro and Rouget.
Sottsass was prominent from the outset, saving ground inside of Chachnak as Persian King established the pace. In Swoop raced just behind Sottsass, alongside Enable. There was little change in the running until the field of 11 runners reached the stretch run.
Persian King was well off the rail giving Demuro an option to go inside or outside of the front-runner. He chose to swing Sottsass to the outside for his run while In Swoop and jockey Ronan Thomas took the inside route. Sottsass hit the front with 200 meters to run, but In Swoop was inching forwardly when they reached the winning post.
The Prix de l'Arc de Triomphe was one of five Group 1 races that were Breeders' Cup Challenge Series events at ParisLongchamp, giving the winners fees-paid berths to the world championship races to be held this year at Keeneland in Lexington, Ky., Nov. 6-7. The connections of the winners also receive $40,000 in travel allowances.
The victory by Sottsass gives him a fees-paid spot in the starting gate for the Turf. Other Group 1 Win and You're In Challenge Series races saw Tiger Tanaka win the Prix Marcel Boussac, giving her a berth in the Juvenile Fillies Turf; Sealiway win the Prix Jean-Luc Lagardere, giving him a berth in the Juvenile Turf; Wooded win the Prix de l'Abbaye de Longchamp, giving him a berth in the Turf Sprint; and Tarnawa win the Prix de l'Opera, giving her a berth in the Filly & Mare Turf.
Enable, who won the 2017-'18 renewals of the Arc (and finished second in 2019) became the first horse to win both the Arc de Triomphe and Breeders' Cup Turf in the same year when she accomplished the feat in 2018.
Peter Brant at Belmont Park
Sottsass, who came into this year's Arc off a fourth-place finish behind Magical in the G1 Irish Champion Stakes at Leopardstown in Ireland on Sept. 12, had finished third behind Waldgeist in the 2019 Arc after earlier in the year winning the G1 French Derby and G2 Prix Niel. The French-bred colt was champion 3-year-old of 2019.
Out of the Galileo mare Starlet's Sister, Sottsass is a half-sister to Brant's American champion Sistercharlie (by Myboycharlie), who gave the owner his first G1 victory after being away from the game for so long when taking the Jenny Wiley at Keeneland in 2018. Brant's horses in the U.S. are trained by Chad Brown.
Brant came back with a splash when he made the decision to return to racing, focusing heavily on broodmares but also buying weanlings and yearlings at both European and American bloodstock auctions. He spent $10 million in 2016 and doubled that investment the following year. Among his yearling purchases in 2017 was Sottass, bred by Ecurie Des Monceaux and purchased for 340,000 euros at the Arqana August Yearling Sale.
In a 2018 interview with the Paulick Report, Brant – who had campaigned such champions as Waya, Just a Game and Gulch in the late 1970s and '80s – spoke about how alliances and partnerships had become an important element in the current iteration of the Thoroughbred industry. As such, earlier this year he sold half-interest in Sottsass to Coolmore, where the Arc winner presumably will stand upon his retirement.
Because of the coronavirus pandemic, the general public was unable to attend the races at ParisLongchamp. Brant, presumably watched his colt win one of the world's most prestigious races from his home in the U.S.
A total of 11 horses trained by Aidan, Joseph, and Donnacha O'Brien will be withdrawn from Sunday's Prix de l'Arc de Triomphe card at Longchamp after a French lab returned positive urine samples for the banned substance Zilpaterol, Racing Post reports.
Four of the O'Brien runners – Mogul, Japan, Sovereign and Serpentine – were set to test Enable in the Group 1 Arc. Fancy Blue, a leading contender for the G1 Prix de l'Opera trained by Donnacha O'Brien, will also scratched.
The withdrawals were announced after Gain Equine Nutrition advised customers to stop using its feed after some batches were found to have been contaminated with Zilpaterol, a substance that's unlicensed in Europe, but is used in the U.S. and elsewhere, primarily to promote weight gain in cattle.
Urine samples from the O'Brien horses were cleared by the Irish Equine Centre, but Aidan O'Brien told Racing Post that a difference in testing methods between the Irish and French laboratories might have produced different results. O'Brien said the Irish test is primarily used to find the drug in cattle, instead of horses.
The Zilpaterol contamination had already caused five positives in France over the past few weeks, and trainer Roger Varian, who also uses Gain products, scratched all seven of his British runners on Saturday, as well.
In 2013, feed made in a California mill and contaminated with Zilpaterol caused a rash of positives in that state, and reached as far as Hong Kong when the feed shipped overseas.
Gain is one of the most widely-used feeds in England and Ireland, meaning a large portion of their racing populations could be exposed to the contaminated feed. However, Racing Post reports that John Gosden, trainer of top Arc contender Enable, does not feed Gain products, thus the mare is not at a risk to scratch due to the contamination.
“Unfortunately, the results of the urine samples taken from the horses yesterday have come back positive from the French laboratory. There is a possibility that the contaminant may have left their system by the time of racing tomorrow, however we have no guarantee of this, and in order to protect the integrity of racing, we have decided to withdraw all our horses from racing tomorrow. Joseph and Donnacha O'Brien will do likewise.”
